首页|生长抑素联合凝血酶治疗肝硬化相关上消化道出血的疗效及肝功能探讨

生长抑素联合凝血酶治疗肝硬化相关上消化道出血的疗效及肝功能探讨

扫码查看
目的 研究生长抑素辅助凝血酶治疗肝硬化相关上消化道出血(Upper Gastrointestinal Bleeding,UGIB)的效果.方法 单纯随机选取新沂市人民医院消化内科于2022年10月—2023年10月收治的80例肝硬化相关UGIB患者为研究对象,以随机数表法分为两组,常规组(n=40)予生长抑素治疗,联合组(n=40)在对照组基础上予凝血酶治疗.比较两组临床指标、治疗效果、凝血功能、肝功能和不良反应发生率.结果 联合组临床指标均优于常规组,差异有统计学意义(P均<0.05).联合组治疗总有效率(100.00%)高于常规组(87.50%),差异有统计学意义(χ2=5.333,P=0.021).联合组凝血酶时间、活化部分凝血活酶时间及凝血酶原时间均短于常规组,而纤维蛋白原高于常规组,差异有统计学意义(P均<0.05).联合组谷草转氨酶、谷丙转氨酶低于常规组,胆碱酯酶高于常规组,差异有统计学意义(P均<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 对肝硬化相关UGIB患者应用生长抑素配合凝血酶治疗能调节临床相关指标、增强疗效,改善凝血功能和肝功能,且不良反应少.
Efficacy and Liver Function of Somatostatin Combined with Thrombin in the Treatment of Upper Gastrointestinal Bleeding Associated with Cirrho-sis
Objective To study the effect of somatostatin assisted thrombin in the treatment of cirrhosis associated up-per gastrointestinal bleeding(UGIB).Methods A total of 80 cirrhosology-related UGIB patients admitted to the Gas-troenterology Department of Xinyi People's Hospital of Jiangsu Province from October 2022 to October 2023 were simple randomly selected as the study objects.They were divided into two groups by random number table method.The conventional group(n=40)was treated with somatostatin,and the combined group(n=40)was treated with throm-bin on the basis of the control group.The clinical indexes,therapeutic effect,coagulation function,liver function and incidence of adverse reactions were compared between the two groups.Results The clinical indexes of combined group were better than those of conventional group,and the differences were statistically significant(all P<0.05).The total ef-fective rate of the combined group(100.00%)was higher than that of the conventional group(87.50%),and the differ-ence was statistically significant(χ2=5.333,P=0.021).Thrombin time,activated partial thrombin time and prothrom-bin time in combination group were shorter than those in conventional group,while fibrinogen time was higher than that in conventional group,and the differences were statistically significant(all P<0.05).The glutamic oxalic amino-transferase and alanine aminotransferase in combination group were lower than those in conventional group,and cho-linesterase was higher than those in conventional group,and the differences were statistically significant(all P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Somatostatin combined with thrombin therapy in cirrhosis related UGIB patients can regulate clinical indicators,en-hance efficacy,improve coagulation function and liver function,and have few side effects,so it is suitable for further promotion.

Upper gastrointestinal bleedingSomatostatinLiver functionLiver cirrhosisThrombin

李征

展开 >

江苏省徐州市新沂市人民医院肝病科,江苏徐州 221400

上消化道出血 生长抑素 肝功能 肝硬化 凝血酶

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(9)